Trial Profile
Canagliflozin-Mealtime Insulin Rescue
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2022
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Aug 2022 Planned End Date changed from 1 Jun 2022 to 1 Dec 2022.
- 19 Jul 2021 Planned End Date changed from 1 Jun 2021 to 1 Jun 2022.
- 20 Jan 2021 Planned End Date changed from 1 Oct 2019 to 1 Jun 2021.